Luc Besançon, Founder and CEO, Pharmacy and Consulting PharmD (Pharmacist)
Luc Besançon is the Founder and CEO of Pharmacy and Consulting, a consulting firm specialised in community pharmacy, with three major domains: innovations and new services, pharmacy policies and partnerships between pharmacy and its key stakeholders.
Luc completed his Doctorat d’État en Pharmacie (PharmD) in 2004 further to an education in France (Université de Bourgogne) and Canada (Université Laval). He also completed a Master’s Degree in Communication (major in European Public Relations) at Paris V – La Sorbonne in 2003.
Prior to creating Pharmacy and Consulting, Luc had worked for almost ten years at the International Pharmaceutical Federation (FIP), including 5 years as the CEO at this global federation which gathers 140 national associations of pharmacists and pharmaceutical scientists.
Prior to FIP, he had worked for five years as a professional adviser for international affairs and for pharmacists’ competence at the Ordre national des pharmaciens, the French body in charge of the regulation of pharmacists.
Peter de Braal
Peter studied financial economics at the Free University of Amsterdam and has been active in health care in various strategic positions in recent years. For 7 years he worked as a consultant for KPMG Healthcare and during the past 9 years he was responsible for the procurement policy of, among other things, Extramural Pharmacy, Intramural Pharmacy / expensive medicines, Natal Care and Diagnostics within Zilveren Kruis Achmea, the biggest health Insurance company in the Netherlands. In 2010 he introduced the IDEA model within extramural pharmacy, a revolutionary purchasing model based on a fixed fee per ddd. In 2015, he introduced a joint purchasing model for intramural pharmacy, for expensive medicines (to be started with TNF-alpha inhibitors), in which 20 hospitals together with Zilveren Kruis collaborated in order to keep costs more manageable and to work on the dossier from a shared agenda. Currently Peter is working as Care manager for Brocacef, where he is responsible for the care programs and interventions that are delivered within the BENU pharmacy formula, a leading pharmaceutical chain and market leader in the Netherlands with over 300 owned pharmacies and over 200 BENU franchise pharmacies. Brocacef is part of Phoenix, an international pharmaceutical service provider, active in 25 countries.
Afonso holds presently an Associate Professor position at the Faculty of Pharmacy, University of Lisbon as well as a visitant professorship (Docent) at the University of Helsinki (Finland). He is responsible for undergraduate social pharmacy teaching as well as postgraduate courses (MSc and Doctoral Programs), lecturing Health Communication, Pharmacy Management and Research Methods in Health. Afonso’s teaching experience comprises also one year of fulltime work at the University of Oslo (Norway).
Presently his main research interests are on customer-provider interaction studies (including non-verbal communication), health information research and patient safety. In this sense, he has been invited to lecture on health communication and qualitative research at several European and Latin American public Universities.
You can find more detailed curriculum vitae here.
Saija Leikola is a PhD with a profound expertise in community pharmacy services, especially medication review and automated unit dose dispensing (ADD). Currently she works as a Development Manager at Pharmac, Finland’s market leading ADD-unit.
Kersti Teder is a hospital pharmacist in Tartu University Hospital and teaching assistant of biopharmacy in Tartu University. She is Estonian Implementation Ambassador in EAHP. Kersti is a board member of Estonian Society of Hospital Pharmacists.
Ülle Helena Meren is currently working as the Head of Pharmacy at East Tallinn Central Hospital, Estonia. She graduated from University of Tartu (MPharm) in 2008 and has been working in hospital pharmacy since 2011. She has been responsible for oncology pharmacy in the hospital ensuring safety and quality management within the pharmacy as well as in the wards administrating hazardous medications. She has taken part in the work of ESOP project Masha (contamination study). Currently she is more focused on procurements and improving quality and efficacy of the whole hospital pharmacy.
Jana Lass: I am a clinical pharmacist working at the Tartu University Hospital. My main fields of interest are intensive care medicines use and paediatric pharmacotherapy and I have been working as a member of the acute pain management team. I defenced my Phd thesis about paediatric medicines use in 2011 and have been since then working as an alternate member of the European Medicines Agency’s Paediatric Committee. I work also part time as an research fellow of Medical Microbiology at the University of Tartu and my main task there is to conduct paediatric academic clinical trials. My teaching activities include teaching clinical pharmacy for pharmacy students and pain management for medical students.
Laimis Dambrauskas is an experienced Chief Pharmacist with a demonstrated history of working in the pharmaceuticals industry. Skilled in Pharmaceutics, Clinical Quality and Regulations, Sales, Strategic Planning, Leadership, Team Building. Strong healthcare services professional with a Master’s degree from Lithuanian University of Health Sciences. Laimis Dambrauskas: Currently I work in the Department of Clinical Pharmacology at Vilnius University Hospital Santaros Klinikos, where I consult and assist on biomedical research related queries. I also participate in international EU funded Joint Action CHRODIS PLUS, where I act as a project specialist in Lithuania.
Aleksandra Aitullina is working as a clinical pharmacist in big tertial hospital (Paul Stradins University hospital) since 2015. Also now she is a teaching staff at Riga Stradins University (RSU), department of Pharmacology and 1st year PhD student. She received her Pharmacy degree and after Master Degree in clinical pharmacy at RSU. During study years she was working in community and hospital pharmacies as well in Latvian Biomedical and biotechnology centre, where Aleksandra was participating in the projects in the molecular biology field (human genetics). Now her research topics are more connected with drug pharmacokinetics and rational drug use in hospital setting.
Dr Inese Sviestiņa (Doctoral degree in Pharmacy) is currently:
• Clinical pharmacist at University Children’s Hospital
• Chair of the Drug and Therapeutics Committee and Antibiotic Stewardship Committee
• Assistant professor in Clinical Pharmacy Faculty of Medicine, University of Latvia
• Member of the Scientific Committee of the EAHP
Dr Sviestiņa graduated with a MSc from the Latvian Medical Academy in 2002. She completed an MSc in Clinical Pharmacy at Rīga Stradiņš University and graduated in 2008. She then completed a doctoral thesis on antibiotic usage in paediatric surgery at Rīga Stradiņš University. Dr Inese Sviestinais has also MA in music pedagogy (1999) and theory of culture (2001).
Dr Sviestiņa has research interests focused on antibiotic stewardship programmes and strategies and antibiotic usage in surgery (both prophylaxis and treatment) mainly in paediatric patients. Furthermore, she is interested in pharmacoeconomy and medicines pricing.